Health technology

PJM. Schmidt CSIRO Molecular and Health Technologies, 343 Royal Parade, ParkviUe 3052, Victoria, AusUalia... 

CCOHTA] Canadian Coordinating Office for Health Technology Assessment (1997). Selective Serotonin Re-uptake Inhibitors (SSRIs) for Major DepressionyVdJxll The Cost-... 

Health Technology Research Center Nano-bioanalysis Team 2217-14 Hayashi-cho, Takamatsu Kagawa 761-0395 Japan... 

Other important documents in HSTAT include the National Institutes of Health (NIH) Consensus Conference Reports and Technology Assessment Reports the HIV/AIDS Treatment Information Service (ATIS) resource documents the Substance Abuse and Mental Health Services Administration s Center for Substance Abuse Treatment (SAMHSA/CSAT) Treatment Improvement Protocols (TIP) and Center for Substance Abuse Prevention (SAMHSA/CSAP) Prevention Enhancement Protocols System (PEPS) the Public Health Service (PHS) Preventive Services Task Force s Guide to Clinical Preventive Services the independent, nonfederal Task Force on Community Services Guide to Community Preventive Services and the Health Technology Advisory Committee (HTAC) of the Minnesota Health Care Commission (MHCC) health technology evaluations. 

To develop and transfer appropriate health technology, information, and standards... 

Erdy DM. 1989. The confidence profile method a Bayesian method for assessing health technologies. Operations Res 37 210-228. 

Using Economic Evaluation in Reimbursement Decisions for Health Technologies... 

Since Australia led the way in 1992, economic evaluation has become a formal component of reimbursement decisions, or the development of national guidance for health technologies, in more than 10 other jurisdictions. These include eight countries of the European Union (Belgium, Finland, Hungary, Ireland, the Netherlands, Portugal, Sweden, and the United Kingdom), plus Canada, New Zealand, and Norway. 

In the United Kingdom, the Department of Health asks NICE to evaluate health technologies that have a major impact on the National Health Service. Although not formally based on efficiency considerations, this approach is more consistent with obtaining the best value for money from the use of resources on economic evaluation. More recently, methods involving the estimation of the expected value of perfect information have been used in a pilot study to inform research priorities in the United Kingdom (Claxton et al. 2004). 

Claxton K., L. GinneUy, M. Sculpher, Z. Philips, and S. Palmer. 2004. A Pilot Study on the Use of Decision Theory and Value of Information Analysis as Past of the National Health Service Technology Assessment Programme. Health Technology Assessment 8(31) (whole issue). 

Sculpher, M. J., F. S. Pang, A. Manca, M. F. Drummond, S. Colder, H. Urdahl, L. M. Davies, and A. Eastwood. 2004. GeneralisabUity in Economic Evaluation Studies in Health Care A Review and Case Studies. Health Technology Assessment 8(49) (whole... 

Lembit Rago, MD, PhD Coordinator, Quality Assurance and Safety of Medicines, Department of Medicines Policy and Standards, Essential Health Technology and Pharmaceuticals, World Health Organization, 20, Avenue Appia, CH-1211 Geneva 27, Switzerland... 

Effects Side Effects of Dental Restorative Materials. National Institutes of Health, Technology Assessment Conference Statement. August 26-28, 1991. 

Canadian Coordinating Office for Health Technology Assessment (CCOHTA). 1994. Guidelines for Economic Evaluations of Pharmaceuticals. Ottawa, Canada CCOHTA. Available at http // www.ccohta.ca [Accessed November 5, 2005]. 

James Orbinski is a research scientist and clinician at St. Michael s Hospital, Toronto, and an Associate Professor of Medicine and Political Science at the University of Toronto. He received his MD degree from McMaster University in 1990, and completed a Masters degree in international relations at the University of Toronto in 1998, before becoming international president of Medecins Sans Frontieres (MSF) from 1998 to 2001. His research interests are focused on access to healthcare, medicines, and other health technologies medical humanitarianism in war and social crisis, and global health policy. 

CCOHTA Canadian Coordinating Office for Health Technology Assessment... 

QOPNA, School of Health Sciences, University of Aveiro, Aveiro, Portugal College of Health Technology of Coimbra, Polytechnic Institute of Coimbra, Coimbra, Portugal... 

Skillen E. L., Berisford C. W., Camann M. A. and Reardon R. C. (1997) Semiochemicals of forest and shade tree insects in North America and management applications. FHTET-96-15, USDA Forest Service, Forest Health Technology Enterprise Team Publication, 182 pp. 

CSIRO Molecular Health Technologies, Bayview Ave., 3169 Clayton,Victoria, Australia chris.strauss csiro.au... 

Eiser, C. and Morse, M. (2001). Quality of Life in chronic diseases of childhood. Health Technology Assess 5(4), 1-157. 

Hoare C, Li Wan Po A and Williams H (2000) Systematic review of treatments for atopic eczema. Health Technology Assessment 4 1-191. 

Petticrew M, Watt I, Sheldon T (1997) Systematic review of the effectiveness of laxatives in the elderly. Health Technology Assessment 1997 1(13). 

CS1RO Division of Molecular and Health Technologies, Clayton, Victoria, 3168, AUSTRALIA Jack. Ryan csiro. au... 

Another, more recent, example is enzyme therapy for Gaucher s disease, an inborn error of metabolism, treated with Ceredase. The therapy, which requires more than a ton of placenta annually to extract and make the drug, can cost as much as 500,000 per year per person, depending on the dosage needed. A 1996 National Institutes of Health technology assessment panel addressed issues in diagnosis and treatment of the disease and concluded that despite the success of enzyme therapy, treatment is limited by the cost. 

The Health Technology Board of Scotland has concluded that in people with alcohol dependence, naltrexone reduces drinking (5). In a multicenter, double-blind, placebo-controlled, 12-week study of naltrexone 50 mg/day in 202 patients with alcohol dependence naltrexone was well tolerated, with few adverse effects abdominal pain (8.6%), headache (7.5%), nausea (6.5%), and dizziness (5.4%) there were no changes in liver function tests (6). However, those who took naltrexone did not have significant improvements in drinking history or fewer relapses. 

Slattery J, Chick J, Cochrane M, Craig J, Godfrey C, Macpherson K, Parrott S, Quinn S, Tochel C, Watson H. Prevention of relapse in alcohol dependence. Health Technology Assessment Report 3. Glasgow Health Technology Board for Scotland, 2003. 

There have been significant developments in the education of technicians and crafts workers prompting the establishment of technical institutes, schools of health technology and trade centres scattered throughout the country. An element of a lower level of skill has been included in the secondary schools curriculum since the 6-3-3-4 Educational system was introduced. 

---